Cumberland Pharmaceuticals Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingNewest
None
No S-3 or F-3 shelf on file in the last 30 months.
$5.8M
Agreement of 2024-03-20. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-07 is not read yet.
Cash
$3.9M
Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗
Raised: 1 of its filings are not read yet.